Second-generation BTK inhibitors show reduced heart-related side effects compared to first-generation inhibitors in B-cell blood cancer patients. Atrial fibrillation occurred in 15.65% of ...
Please provide your email address to receive an email when new articles are posted on . First-generation BTK inhibitors and preexisting cardiovascular disease linked to higher odds of CVAEs. More than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results